The latest biotech to roll out of Third Rock Ventures is working on Fc-based therapeutics it hopes could offer new treatment ...

Merida is working on a selective therapy for Graves’ disease, leveraging targeted therapies that can deplete disease-causing ...

Avoiding certain foods, as advised in the past, may actually increase the risk of children developing allergies ...

Keymed Biosciences Inc. (HKEX: 02162) ('Keymed' or the 'Company') today announced that the prestigious medical journal Nature Medicine has published the results from the Phase III trial of its ...

Keymed Biosciences Inc. (HKEX: 02162) ("Keymed" or the "Company") today announced that the prestigious medical journal Nature Medicine has published ...

The long-term safety and efficacy of omalizumab, alongside promising phase 3 trial results that demonstrated the efficacy and ...

Symptoms of seasonal allergies and the common cold can overlap. Learn how to tell them apart so you can get the treatment you need.

A patch test for atopic dermatitis helps identify triggers and confirms diagnosis. Learn about self-testing and specialists ...

The company’s Phase I trial saw nearly all patients in the trial reaching their targeted maximum dose of DM-101PX.

As spring arrives with blooming flowers and warmer weather, so too come the sneezing, itchy eyes, and runny noses that plague ...

The short-course treatment was found to be safe and well tolerated in birch pollen allergic patients and to induce a very strong and sustained allergen-specific IgG4 response. DM-101PX-induced ...

Medically reviewed by Daniel More, MD Allergies occur when your immune system overreacts to allergens like pet dander, pollen ...